logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/09/2025
The Apple Watch's high blood pressure detection function has been approved by the US Food and Drug Administration.
Latest
2 m ago
KPMG's 2025 Government Policy Report suggests considering the introduction of a fractional share trading system and increasing after-hours trading.
3 m ago
CMB International Securities: Target price for Cheesecake City Technology (09911.HK) is 16.2 Hong Kong dollars, expected to maintain strong momentum.
3 m ago
AstraZeneca's long-acting C5 complement inhibitor Ultomiris has been launched in China.
3 m ago
AstraZeneca announces that the long-acting C5 complement inhibitor Ultomiris (generic name: ravulizumab injection) has been officially launched in China for use in combination with conventional treatment drugs for the treatment of adult generalized myasthenia gravis (gMG) patients who are positive for anti-acetylcholine receptor (AChR) antibodies, as well as for the treatment of adult neuromyelitis optica spectrum disorder (NMOSD) patients who are positive for anti-aquaporin-4 (AQP4) antibodies.
5 m ago
Stock anomaly in Hong Kong | Brainstorm Aurora (06681.HK) surged over 50% to a new high, recently included in the Hong Kong Stock Connect list, core pipeline made significant progress.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.